PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease

Published:2024-01 Issue: Volume:150 Page:155736
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Sachan Vatsal,Le Dévéhat Maïlys,Roubtsova Anna,Essalmani Rachid,Laurendeau Jean-Francois,Garçon Damien,Susan-Resiga Delia,Duval Stéphanie,Mikaeeli Sahar,Hamelin Josée,Evagelidis Alexandra,Chong Michael,Paré Guillaume,Chernetsova Elizabeta,Gao Zu-Hua,Robillard Isabelle,Ruiz Matthieu,Trinh Vincent Quoc-Huy,Estall Jennifer L.,Faraj May,Austin Richard C.,Sauvageau Martin,Prat Annik,Kiss Robert S.,Seidah Nabil G.^ORCID

Funder

CIHR

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference81 articles.

1. cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin- like proteinases;Seidah;Proc Natl Acad Sci U S A,1996

2. The biology and therapeutic targeting of the proprotein convertases;Seidah;Nat Rev Drug Discov,2012

3. The Proprotein Convertase PC7: unique zymogen activation and trafficking pathways;Rousselet;J Biol Chem,2011

4. Implication of the proprotein convertases in iron homeostasis: proprotein convertase 7 sheds human transferrin receptor 1 and furin activates hepcidin;Guillemot;Hepatology,2013

5. The motif EXEXXXL in the cytosolic tail of the secretory human proprotein convertase PC7 regulates its trafficking and cleavage activity;Durand;J Biol Chem,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oligonucleotide therapies for nonalcoholic steatohepatitis;Molecular Therapy - Nucleic Acids;2024-06

2. Is MASLD lost in translation in mice?;Trends in Endocrinology & Metabolism;2024-06

3. Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin;Frontiers in Endocrinology;2024-05-23

4. Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies;Pharmacological Reviews;2024-01-30